Value of CXCL8–CXCR1/2 axis in neoadjuvant chemotherapy for triple-negative breast cancer patients: a retrospective pilot study

2020 ◽  
Vol 181 (3) ◽  
pp. 561-570
Author(s):  
Ruo-Xi Wang ◽  
Peng Ji ◽  
Yue Gong ◽  
Zhi-Ming Shao ◽  
Sheng Chen
Keyword(s):  
Breast Cancer ◽  
Pilot Study ◽  
Neoadjuvant Chemotherapy ◽  
Cancer Patients ◽  
Triple Negative Breast Cancer ◽  
Triple Negative ◽  
Breast Cancer Patients

scholarly journals BRCAness and Prognosis in Triple-Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy

PLoS ONE ◽  
2016 ◽  
Vol 11 (12) ◽  
pp. e0165721 ◽  
Author(s):  
Hirokazu Tanino ◽  
Yoshimasa Kosaka ◽  
Hiroshi Nishimiya ◽  
Youko Tanaka ◽  
Naoko Minatani ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Neoadjuvant Chemotherapy ◽  
Cancer Patients ◽  
Triple Negative Breast Cancer ◽  
Triple Negative ◽  
Breast Cancer Patients

scholarly journals Practical consensus recommendations for neo-adjuvant chemotherapy in triple negative breast cancer

2018 ◽  
Vol 07 (02) ◽  
pp. 156-158
Author(s):  
G. S. Bhattacharyya ◽  
M. Walia ◽  
M. Nandi ◽  
A. Murli ◽  
S. Salim ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Adjuvant Chemotherapy ◽  
Neoadjuvant Chemotherapy ◽  
Cancer Patients ◽  
Triple Negative Breast Cancer ◽  
Triple Negative ◽  
Breast Cancer Patients ◽  
Consensus Recommendation ◽  
Consensus Recommendations ◽  
Neo Adjuvant Chemotherapy

AbstractThis manuscript provides a practical and easy to use consensus recommendation to community oncologists on how to use neoadjuvant chemotherapy in triple negative breast cancer patients.

Sign in / Sign up

Export Citation Format

Share Document